|
New business spotlight on Desiree Itsell, Arbonne consultant
Pure. Safe. Beneficial. Those three words are what Arbonne Swiss skin care products are all about. And Desiree Itsell, an independent consultant for the Arbonne company, is excited to sell the products with her team of four people. “Our products don't have things like animal byproducts, minerals, chemical perfumes and dyes," Itsell said. The products are also all manufactured in the U.S., she said. The company offers different products for women, teens, men and even babies. Itsell said the products are especially good for people with sensitive skin. Arbonne has products that appeal to everyone, Itsell said. “Arbonne's tagline is from the cradle to the rocker," Itsell said. There is a teen line called f.y.i., for young individuals, anti-aging products, acne products and weight loss and nutrition products.
Scientific Study Reveals Powerful Skin Regeneration Properties of Snail Secretion Available in BIOCUTIS Skin Care ...
Latest scientific research published in The Journal of The International Society of Skin Pharmacology has revealed the regenerative properties of the secretion of snails and its invaluable effects on human skin. Andes Natural Skin Care LLC presents the natural skin care product line BIOCUTIS(r) that includes this ingredient which promises to restore beauty & health back to your skin, naturally! Carson City, NV (PRWEB) February 4, 2008 -- Scientific research published by the Journal "Skin Pharmacology and Physiology" in their issue of January 2008; 21:15-22, has revealed the regenerative properties of the secretion of snails and its invaluable effects on the skin. Andes Natural Skin Care LLC includes this regenerative skin ingredient in a new line of natural skin care products available with the trade mark BIOCUTIS(r).
OmniReliant Holdings, Inc. Acquires Topical Pharmaceutical Patent
OmniReliant Holdings, Inc., ("OmniReliant" or the "Company") (OTCBB:ORHI), licensee of Kathy Hilton Fragrance, announced today that it has formally acquired the rights to a unique patented topical pharmaceutical product capable of delivering salicylic acid in a non-stick clear solid composition to treat acne. OmniReliant will use the patented product to compliment the company's patent pending warming foam acne treatment product. Lead scientists William Bess and Leonard Mackles, who conceived the product, have agreed to sell the patent and collaborate with OmniReliant Holdings, Inc. to bring this breakthrough formula to the highly competitive acne treatment market. Paul W. Morrison, CEO of OmniReliant Holdings, Inc., said, "Management considers it is important to acquire patented technology in order to contend in the aggressive acne treatment market.
Alarming numbers of teenagers sunburnt: Cancer Council
But National Skin Cancer Committee chairman Craig Sinclair says almost 400,000 adolescents were still getting burnt each weekend last summer. "A quarter of all adolescents aged between 12 and 17 are still getting sunburnt on a typical summer weekend," he said. "What we know about the evidence between the link between sunburn and skin cancer later in life, this is certainly a real concern to the cancer councils." The study of 5,000 adults and 650 teenagers found girls are more likely to deliberately tan than boys. Mr Sinclair says an emotional TV advertisement is being launched, featuring 26-year-old Clare Oliver, who died from a melanoma last year. "Along with this data we're releasing today is a new television commercial, which highlights her tragic death and the importance of early detection in relation to melanoma," he said.
Acid peels help acne go away
ST. LOUIS, Feb. 7 (UPI) -- Alpha-hydroxy and beta-hydroxy acid peels are very effective in treating mild to moderate facial acne, U.S. researchers said.
The study, published in Dermatologic Surgery, found both types of chemical peels significantly reduced acne lesions within two weeks of the first treatment, and patients continued to see a reduction in lesions through the first follow-up visit a month after the treatments.
"This is good news for the millions of Americans who suffer from mild to moderately severe facial acne," Dr. Dee Anna Glaser of the Saint Louis University School of Medicine said in a statement. "This provides more options for patients and doctors to chose from when it comes to tailoring a treatment program for each individual."
The study involved mild/moderate acne patients with an average age of 24 years -- 13 women and seven men -- treated every other week with a treatment involving the application of alpha-hydroxy acid to one side of the face and beta-hydroxy acid to the other side.
|
